Galenica AG/Fr. GALE
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Galenica AG
Galenica AG operates within the healthcare sector, focusing on pharmaceutical distribution, retail, and services in Switzerland. Its core business includes the distribution of medicines and health products, operating one of the largest pharmacy networks, and providing specialized healthcare logistics and digital services. Founded in 1927 and headquartered in Bern, Switzerland, Galenica leverages its extensive network and partnerships to maintain a strong presence in the Swiss market. The company is strategically positioned through its integration across the pharmaceutical supply chain, offering a comprehensive range of products and services to improve healthcare accessibility and efficiency.
Ticker
Fr. GALE
Sector
Primary listing
XSWX
Employees
6,577
Headquarters
Bern, Switzerland
Website
Galenica AG Metrics
BasicAdvanced
CHF 4.1bn
23.02
CHF 3.63
0.35
CHF 2.50
1.50%
Price and volume
Market cap
CHF 4.1bn
Beta
0.35
52-week high
CHF 103.00
52-week low
CHF 81.10
Average daily volume
94k
Dividend rate
CHF 2.50
Financial strength
Current ratio
1.147
Quick ratio
0.688
Long term debt to equity
52.386
Total debt to equity
70.088
Dividend payout ratio (TTM)
63.56%
Interest coverage (TTM)
16.85%
Profitability
EBITDA (TTM)
267.456
Gross margin (TTM)
12.17%
Net profit margin (TTM)
4.37%
Operating margin (TTM)
5.47%
Effective tax rate (TTM)
17.31%
Revenue per employee (TTM)
CHF 630,000
Management effectiveness
Return on assets (TTM)
4.45%
Return on equity (TTM)
12.11%
Valuation
Price to earnings (TTM)
23.017
Price to revenue (TTM)
1.004
Price to book
2.8
Price to tangible book (TTM)
60.97
Price to free cash flow (TTM)
17.058
Free cash flow yield (TTM)
5.86%
Free cash flow per share (TTM)
4.895
Dividend yield (TTM)
2.99%
Forward dividend yield
1.50%
Growth
Revenue change (TTM)
5.48%
Earnings per share change (TTM)
-1.11%
3-year revenue growth (CAGR)
4.86%
10-year revenue growth (CAGR)
3.57%
3-year earnings per share growth (CAGR)
3.09%
10-year earnings per share growth (CAGR)
8.38%
3-year dividend per share growth (CAGR)
4.35%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs